Oct. 25, 2021 Price forecast | 2 weeks: -3.28% | 1 month: -3.89% | 3 months: -4.30%


ALVR stock forecast

Our latest prediction for AlloVir Inc's stock price was made on the Oct. 25, 2021 when the stock price was at 24.67$.

In the short term (2weeks), ALVR's stock price should underperform the market by -3.28%. During that period the price should oscillate between -11.88% and +10.16%.

In the medium term (3months), ALVR's stock price should underperform the market by -4.30%. During that period the price should oscillate between -36.19% and +29.54%.

Create a solid portfolio with ALVR

Add ALVR to your portfolio and optimize it!


About AlloVir Inc

AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.87$ per share.

The book value per share is 1.80$

AlloVir Inc website


Three months stock forecastOct. 25, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -118M -316.80% -117M -1.87 - - 63M 1.80 -81M - -82M